» Articles » PMID: 11895860

Nrf2 Transactivator-independent GSTP1-1 Expression in "GSTP1-1 Positive" Single Cells Inducible in Female Mouse Liver by DEN: a Preneoplastic Character of Possible Initiated Cells

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2002 Mar 16
PMID 11895860
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Whether single cells immunohistochemically positive for glutathione S-transferase P1-1 (GSTP1-1) induced in the female mouse liver by DEN (Hatayama et al., Carcinogenesis, 14, 537-538, 1993) are precursor initiated cells of preneoplastic foci, is of importance in chemical hepatocarcinogenesis. Nrf2 transactivates a wide variety of ARE (anti-oxidant response element)-mediated enzymes including GSTP1-1. Quantitative examination revealed that the basal expression of hepatic GSTP1-1 was 60% lower in Nrf2 gene knock-out female mice(-/-) than in wild type females, and that treatment with butyrated hydroxyanisole (BHA) increased by 10-fold GSTP1-1 expression in the liver of wild type female mice but not in knockout female mice(-/-). Despite the lack of Nrf2, GSTP1-1-positive single cells were detected in livers of DEN-treated female(-/-) 3 months after treatment. Subsequent BHA feeding to the positive cell-bearing females for one more week clearly showed that the single cells were detectable with females(-/-) but not with females(+/+,+/-) due to the strong induction of GSTP1-1 in the surrounding hepatocytes. The sensitivity to DEN hepatocarcinogenesis was not significantly different among genotypes. These results demonstrate that Nrf2 is regulatory in normal hepatocytes but not in the single cells positive for GSTP1-1 inducible in the female mouse liver by DEN. The transcriptional distinction observed for the DEN-transformants is suggestive of a preneoplastic character of precursor initiated cells.

Citing Articles

Superior cuproptotic efficacy of diethyldithiocarbamate-CuO nanoparticles over diethyldithiocarbamate-CuO nanoparticles in metastatic hepatocellular carcinoma.

Abu-Serie M, Barakat A, Ramadan S, Habashy N Front Pharmacol. 2024; 15:1388038.

PMID: 39076585 PMC: 11284037. DOI: 10.3389/fphar.2024.1388038.


Genetic and epigenetic regulation and expression signatures of glutathione S-transferases in developing mouse liver.

Cui J, Choudhuri S, Knight T, Klaassen C Toxicol Sci. 2010; 116(1):32-43.

PMID: 20395309 PMC: 2886863. DOI: 10.1093/toxsci/kfq115.


Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.

Fan Y, Shimizu T, Yamada T, Nanashima N, Akita M, Asano J Cancer Sci. 2007; 99(3):497-501.

PMID: 18081878 PMC: 11159688. DOI: 10.1111/j.1349-7006.2007.00703.x.


Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity.

Pacchioni A, Vallone J, Melendez R, Shih A, Murphy T, Kalivas P Brain Res. 2006; 1127(1):26-35.

PMID: 17113054 PMC: 1831835. DOI: 10.1016/j.brainres.2006.10.036.


Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.

Niu Z, Wang M World J Gastroenterol. 2005; 11(28):4404-8.

PMID: 16038042 PMC: 4434670. DOI: 10.3748/wjg.v11.i28.4404.